AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on November 2, 2026

Personal AI Raises a New Question: Who Controls the Algorithmic Portrait of an Individual
Boston Wedding Photographer Offers One Free Wedding a Year to a Couple Facing Hardship; Nominations Close December 12
Twisted Tea is Making the Holiday Countdown Even More Twisted with its 25 Days of Twistmas Calendar
Global Virtual Mirror Market to Reach $20.2 Billion by 2031, Driven by Omnichannel Retail Expansion and AI-Powered Virtual Try-On Adoption
Quiet Communities Launches Free Science-based Resource Hub to Help Communities Address Data Center Noise
Phoenix Tailings Hosts Department of Energy Assistant Secretary at New Hampshire, Rare Earth Metallization Facility
Ahold Delhaize USA Advances Next-Generation In-Store Experience
IDC Research Names Lisa Nadler Chief People Officer
Compass Therapeutics to Participate in Upcoming November Investor Events
Bicara Therapeutics to Report Third Quarter 2026 Financial Results and Business Updates on November 9, 2026, at 8:30 AM ET
Disc Medicine to Participate in Upcoming Investor Conferences
Lantheus Announces Presentation of Data at the 2026 Clinical Trials on Alzheimer’s Disease Annual Meeting
Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences
Club Fit Brings Mouratoglou Tennis to Westchester with Two New Tennis Centers in Briarcliff and Jefferson Valley
Crescent Biopharma to Present at November Investor Conferences
uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease
Climb Bio to Present at Guggenheim 3rd Annual Healthcare Innovation Conference
Rapport Announces Closing of Public Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Notes, as well as Concurrent Private Placement
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Ocular Therapeutix™ to Report Third Quarter 2026 Financial Results on November 9, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.